Abstract
Gram-negative bacteria have a cell envelope that comprises an outer membrane (OM), a peptidoglycan (PG) layer and an inner membrane (IM)1. The OM and PG are load-bearing, selectively permeable structures that are stabilized by cooperative interactions between IM and OM proteins2,3. In Escherichia coli, Braun’s lipoprotein (Lpp) forms the only covalent tether between the OM and PG and is crucial for cell envelope stability4; however, most other Gram-negative bacteria lack Lpp so it has been assumed that alternative mechanisms of OM stabilization are present5. We used a glycoproteomic analysis of PG to show that β-barrel OM proteins are covalently attached to PG in several Gram-negative species, including Coxiella burnetii, Agrobacterium tumefaciens and Legionella pneumophila. In C. burnetii, we found that four different types of covalent attachments occur between OM proteins and PG, with tethering of the β-barrel OM protein BbpA becoming most abundant in the stationary phase and tethering of the lipoprotein LimB similar throughout the cell cycle. Using a genetic approach, we demonstrate that the cell cycle-dependent tethering of BbpA is partly dependent on a developmentally regulated L,D-transpeptidase (Ldt). We use our findings to propose a model of Gram-negative cell envelope stabilization that includes cell cycle control and an expanded role for Ldts in covalently attaching surface proteins to PG.
Original language | English |
---|---|
Pages (from-to) | 19-26 |
Number of pages | 8 |
Journal | Nature Microbiology |
Volume | 6 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2021 |
Funding
We thank M. Suzuki, A. E. Acosta Martin and M. Collins for their contribution to developing the MS method and V. Nair for his help with cryo-EM. We thank R. Kissinger for his three-dimensional modelling, with assistance from A. Athman, and A. Mora for graphics support. We thank X. De Bolle and P. Godessart for stimulating discussion and J. Zupan, P. Zambryski, D. Kelly, A. Taylor, J. Shaw, E. F. Diaz Parga, R. Wheeler, I. Boneca, M.-K. Taha and E. Hoiczyk for the bacterial cultures used for peptidoglycan extraction. The PG MS analyses were performed by the biOMICS Facility of the Faculty of Science Mass Spectrometry Centre at the University of Sheffield, UK and the Research Technologies Branch at the National Institutes of Health (NIH) in Rockville, USA. The cryo-EM work was performed at the Research Technologies Branch at the NIH in Hamilton, USA. This work was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (R.A.H. and S.A.P.), a Medical Research Council grant no. MR/S009272/1 (S.M.) and a Biotechnology and Biological Sciences Research Council grant no. BBSRC BB/N000951/1 (S.M.). R.E.S. and A.V.P. are supported by a Biotechnology and Biological Sciences Research Council studentship (doctoral training program grant no. BB/M011151/1). J.C.G. acknowledges support from the NIH under grant no. R01-GM123169. C.J.C. was supported by a National Science Foundation (NSF) Graduate Research Fellowship under grant no. 2017219379. J.M.P. was supported by the Laboratory Directed Research and Development program at Oak Ridge National Laboratory, which is managed by UT-Battelle for the US Department of Energy under contract no. DE-AC05-00OR22725. This work used resources of the Compute and Data Environment for Science at Oak Ridge National Laboratory as well as the Extreme Science and Engineering Discovery Environment (allocation no. TG-MCB130173), which is supported by an NSF grant no. ACI-1548562.
Funders | Funder number |
---|---|
Extreme Science and Engineering Discovery Environment | TG-MCB130173 |
US Department of Energy | DE-AC05-00OR22725 |
UT-Battelle | |
National Science Foundation | 2017219379, ACI-1548562 |
National Science Foundation | |
National Institutes of Health | R01-GM123169 |
National Institutes of Health | |
National Institute of Allergy and Infectious Diseases | |
Oak Ridge National Laboratory | |
Division of Intramural Research, National Institute of Allergy and Infectious Diseases | ZIAAI001105, ZIA AI000931-18 |
Division of Intramural Research, National Institute of Allergy and Infectious Diseases | |
Medical Research Council | MR/S009272/1 |
Medical Research Council | |
Biotechnology and Biological Sciences Research Council | BB/N000951/1, BB/M011151/1 |
Biotechnology and Biological Sciences Research Council |